Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) Short Interest Down 16.6% in March

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) saw a large decrease in short interest during the month of March. As of March 31st, there was short interest totalling 646,100 shares, a decrease of 16.6% from the March 15th total of 774,400 shares. Based on an average daily trading volume, of 1,040,000 shares, the days-to-cover ratio is currently 0.6 days. Approximately 3.1% of the company’s stock are short sold.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on EKSO. HC Wainwright reiterated a “buy” rating and set a $9.00 price target on shares of Ekso Bionics in a research report on Tuesday, March 4th. Lake Street Capital decreased their price objective on shares of Ekso Bionics from $2.00 to $1.00 and set a “buy” rating on the stock in a report on Tuesday, March 4th. Finally, StockNews.com initiated coverage on Ekso Bionics in a report on Sunday. They set a “hold” rating on the stock.

Ekso Bionics Stock Performance

EKSO stock opened at $0.41 on Tuesday. Ekso Bionics has a 12-month low of $0.34 and a 12-month high of $1.53. The company has a quick ratio of 2.14, a current ratio of 2.81 and a debt-to-equity ratio of 0.28. The business has a 50 day moving average of $0.45 and a 200-day moving average of $0.64. The firm has a market cap of $11.85 million, a PE ratio of -0.63 and a beta of 1.33.

Ekso Bionics (NASDAQ:EKSO) last issued its earnings results on Monday, March 3rd. The company reported ($0.14) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.07) by ($0.07). The firm had revenue of $5.09 million during the quarter, compared to the consensus estimate of $5.05 million. Ekso Bionics had a negative return on equity of 83.09% and a negative net margin of 62.95%. As a group, sell-side analysts expect that Ekso Bionics will post -0.48 earnings per share for the current year.

Ekso Bionics Company Profile

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.